Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bold Brain Capital is a venture capital firm established in 2018 and headquartered in Durham, North Carolina. The firm specializes in early-stage investments in life sciences, particularly focusing on AI-enabled healthcare technologies. By engaging physicians as limited partners, Bold Brain Capital enhances its investment strategy with clinical insights that are critical for the development of effective medical AI solutions.
The firm has built a significant network of physician investors, known as the Bold Brain Network, which plays a crucial role in sourcing deals and conducting due diligence. This network not only co-invests alongside the firm but also provides valuable consulting opportunities within portfolio companies, leveraging the expertise of its physician partners to improve product development and market fit.
As of now, Bold Brain Capital manages a portfolio of eight companies and continues to seek innovative startups that align with its mission of improving patient care through AI technologies. The firm operates primarily in North America, focusing on the United States.
Bold Brain Capital invests in early-stage life sciences companies that are pioneering AI technologies in healthcare. The firm targets Seed through Series C funding rounds, emphasizing the importance of physician involvement in the development of medical AI. This approach is rooted in the belief that clinical insights are essential for creating solutions that are both deployable and clinically useful.
The sectors of interest include healthcare, artificial intelligence, and biotechnology. Bold Brain Capital seeks companies that are developing transformative AI technologies aimed at improving patient care and outcomes. The firm’s investment strategy is designed to ensure that the clinical perspective is integrated into the investment process, thereby enhancing the potential for successful deployment of medical AI solutions.
Bold Brain Capital's portfolio includes eight notable companies, primarily focused on AI technologies in healthcare:
This portfolio reflects Bold Brain Capital's thematic concentration in medical imaging and clinical decision support, showcasing its commitment to advancing AI technologies that can significantly impact patient care.
Mike Thomas: Managing Partner at Bold Brain Capital, Mike has a proven track record of raising $125 million and achieving shareholder returns ranging from 4x to 80x. He has led one IPO and one acquisition in his previous roles.
Tom Deur, MD: Co-Founder and Managing Partner, Tom has led investments in several portfolio companies, including Elucid, Vista.AI, and Bunker Hill. His medical background enhances the firm's focus on clinical insights in investment decisions.
Robin Prasad, MD, MS, MBA: As a Managing Partner, Robin brings a wealth of experience in healthcare and investment, contributing to the firm's strategic direction and investment decisions.
Will Anlyan: Managing Partner overseeing marketing and capital formation, Will plays a key role in managing the Bold Brain Network and ensuring effective communication with physician investors.
To pitch Bold Brain Capital, founders should send an email to info@boldbrain.vc. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and how the technology addresses a specific healthcare need.
While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the firm's emphasis on physician involvement and clinical insights. Warm introductions through the Bold Brain Network may enhance the chances of receiving a timely response.
Bold Brain Capital offers opportunities for physicians to invest alongside the firm in healthcare AI technologies. This initiative allows physician investors to engage directly with innovative startups, providing both capital and clinical insights.
Additionally, the firm provides potential consulting opportunities within its portfolio companies, leveraging the expertise of its physician partners to enhance product development and market fit. This dual approach strengthens the connection between investment and clinical application in the healthcare sector.
In September 2024, Bold Brain Capital participated in the Series A funding round for Segmed, a company focused on curating medical datasets for AI development in medical imaging. This investment aligns with the firm's strategy of supporting innovative healthcare AI solutions.
Additionally, Bold Brain Capital continues to expand its Bold Brain Network, enhancing its ability to source and conduct due diligence on potential investments. The firm remains active in the healthcare AI space, seeking opportunities that align with its mission of improving patient care through technology.
What are Bold Brain Capital's investment criteria?
Bold Brain Capital focuses on early-stage life sciences companies that are developing AI technologies in healthcare. The firm emphasizes the importance of physician involvement in the development process, ensuring that clinical insights are integrated into the investment strategy.
How can I pitch to Bold Brain Capital?
Founders can reach out via email at info@boldbrain.vc. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and how the technology addresses a specific healthcare need.
What makes Bold Brain Capital different from other VCs?
The unique aspect of Bold Brain Capital is its Bold Brain Network, which consists of hundreds of physician investors. This network not only co-invests but also provides critical clinical insights that enhance the investment process and product development.
What is the geographic focus of Bold Brain Capital?
While based in Durham, North Carolina, Bold Brain Capital primarily invests in companies located in the United States. However, the firm is open to opportunities that may arise outside this geographic boundary.
What is the typical check size for investments?
The specific check sizes are not publicly disclosed, but Bold Brain Capital typically participates in Seed through Series C funding rounds, indicating a focus on early-stage investments.
What kind of post-investment support does Bold Brain Capital provide?
Bold Brain Capital offers consulting opportunities within its portfolio companies, leveraging the expertise of its physician partners to enhance product development and market fit. This support is crucial for startups looking to navigate the complexities of the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.